ステムセル研究所の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/04/21 | 1,332 | 1,360 | 1,318 | 1,360 | +15 | +1.1% | 5,600 |
2025/04/18 | 1,329 | 1,349 | 1,295 | 1,345 | +16 | +1.2% | 8,800 |
2025/04/17 | 1,333 | 1,348 | 1,317 | 1,329 | -4 | -0.3% | 8,400 |
2025/04/16 | 1,305 | 1,333 | 1,287 | 1,333 | +18 | +1.4% | 6,000 |
2025/04/15 | 1,289 | 1,321 | 1,289 | 1,315 | +26 | +2% | 2,100 |
2025/04/14 | 1,340 | 1,340 | 1,289 | 1,289 | -21 | -1.6% | 4,800 |
2025/04/11 | 1,290 | 1,324 | 1,271 | 1,310 | ±0 | ±0% | 5,900 |
2025/04/10 | 1,294 | 1,333 | 1,262 | 1,310 | +106 | +8.8% | 11,300 |
2025/04/09 | 1,278 | 1,278 | 1,199 | 1,204 | -74 | -5.8% | 10,600 |
2025/04/08 | 1,204 | 1,278 | 1,204 | 1,278 | +94 | +7.9% | 8,100 |
2025/04/07 | 1,101 | 1,280 | 1,100 | 1,184 | -105 | -8.1% | 37,900 |
2025/04/04 | 1,342 | 1,349 | 1,266 | 1,289 | -83 | -6% | 19,800 |
2025/04/03 | 1,299 | 1,374 | 1,262 | 1,372 | +23 | +1.7% | 35,300 |
2025/04/02 | 1,359 | 1,362 | 1,340 | 1,349 | -16 | -1.2% | 15,800 |
2025/04/01 | 1,365 | 1,398 | 1,362 | 1,365 | +8 | +0.6% | 11,700 |
2025/03/31 | 1,377 | 1,378 | 1,345 | 1,357 | -28 | -2% | 13,700 |
2025/03/28 | 1,420 | 1,446 | 1,382 | 1,385 | -30 | -2.1% | 25,100 |
2025/03/27 | 1,387 | 1,415 | 1,364 | 1,415 | +35 | +2.5% | 24,000 |
2025/03/26 | 1,352 | 1,394 | 1,342 | 1,380 | +31 | +2.3% | 14,800 |
2025/03/25 | 1,354 | 1,367 | 1,342 | 1,349 | +1 | +0.1% | 10,000 |
2025/03/24 | 1,333 | 1,348 | 1,320 | 1,348 | +14 | +1% | 13,000 |
2025/03/21 | 1,409 | 1,431 | 1,334 | 1,334 | -96 | -6.7% | 39,200 |
2025/03/19 | 1,431 | 1,449 | 1,415 | 1,430 | -1 | -0.1% | 33,800 |
2025/03/18 | 1,378 | 1,457 | 1,378 | 1,431 | +53 | +3.8% | 47,300 |
2025/03/17 | 1,411 | 1,411 | 1,358 | 1,378 | -52 | -3.6% | 79,300 |
2025/03/14 | 1,386 | 1,462 | 1,353 | 1,430 | +14 | +1% | 77,100 |
2025/03/13 | 1,371 | 1,454 | 1,371 | 1,416 | +45 | +3.3% | 83,300 |
2025/03/12 | 1,323 | 1,403 | 1,320 | 1,371 | +48 | +3.6% | 71,100 |
2025/03/11 | 1,225 | 1,323 | 1,223 | 1,323 | +98 | +8% | 95,100 |
2025/03/10 | 1,195 | 1,244 | 1,193 | 1,225 | +38 | +3.2% | 62,700 |
2025/03/07 | 1,152 | 1,204 | 1,141 | 1,187 | +28 | +2.4% | 79,400 |
2025/03/06 | 1,153 | 1,170 | 1,130 | 1,159 | +21 | +1.8% | 38,300 |
2025/03/05 | 1,150 | 1,162 | 1,128 | 1,138 | -21 | -1.8% | 85,500 |
2025/03/04 | 1,144 | 1,173 | 1,114 | 1,159 | -15 | -1.3% | 84,000 |
2025/03/03 | 1,192 | 1,192 | 1,158 | 1,174 | -41 | -3.4% | 53,100 |
2025/02/28 | 1,163 | 1,217 | 1,160 | 1,215 | +27 | +2.3% | 83,000 |
2025/02/27 | 1,128 | 1,199 | 1,097 | 1,188 | +54 | +4.8% | 258,800 |
2025/02/26 | 1,146 | 1,162 | 1,126 | 1,134 | -51 | -4.3% | 338,400 |
2025/02/25 | 1,181 | 1,194 | 1,155 | 1,185 | -10 | -0.8% | 76,100 |
2025/02/21 | 1,220 | 1,222 | 1,195 | 1,195 | -25 | -2% | 66,300 |
2025/02/20 | 1,200 | 1,226 | 1,190 | 1,220 | +19 | +1.6% | 68,400 |
2025/02/19 | 1,228 | 1,234 | 1,200 | 1,201 | -26 | -2.1% | 49,900 |
2025/02/18 | 1,240 | 1,240 | 1,196 | 1,227 | -43 | -3.4% | 94,900 |
2025/02/17 | 1,359 | 1,359 | 1,250 | 1,270 | -102 | -7.4% | 52,200 |
2025/02/14 | 1,252 | 1,409 | 1,251 | 1,372 | -155 | -10.2% | 101,000 |
2025/02/13 | 1,485 | 1,543 | 1,485 | 1,527 | +2 | +0.1% | 19,400 |
2025/02/12 | 1,485 | 1,541 | 1,485 | 1,525 | +24 | +1.6% | 12,600 |
2025/02/10 | 1,486 | 1,528 | 1,486 | 1,501 | +15 | +1% | 4,100 |
2025/02/07 | 1,496 | 1,505 | 1,481 | 1,486 | -24 | -1.6% | 10,200 |
2025/02/06 | 1,527 | 1,527 | 1,490 | 1,510 | -17 | -1.1% | 10,400 |
101~
150
件表示中 / 1035件
類似銘柄と比較する
現在ご覧いただいている「ステムセル研」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ステムセル研 | 94,400円 | +12.0% | +5.1% | 0.00% | 29.70倍 | 3.62倍 |
|
臍帯血の処理・保管の細胞バンク事業で国内民間市場ほぼ独占。臍帯保管や新規事業に展開図る |
Schoo | 78,500円 | +17.9% | +171.3% | 0.00% | 67.97倍 | 5.16倍 |
|
法人向けオンライン研修が柱。ビジネス・デジタルスキル軸に8000本超のコンテンツ内製 |
ビケンテクノ | 125,500円 | +3.8% | +3.4% | 2.23% | 8.61倍 | 0.44倍 |
|
清掃、警備、設備管理などの総合ビルメンテ、衛生管理業務を展開。病院買収で介護ビジネスも |
ARM | 59,000円 | +16.0% | +11.4% | 2.88% | 11.88倍 | 2.37倍 |
|
ストレスチェックと関連ビジネスで首位級。団体長期障害所得補償保険(GLTD)も販売 |
FCHD | 141,100円 | - | - | - | - | 1.12倍 |
|
道路、橋梁、鉄道の調査、設計コンサルタントが中心。交通調査・自治体都市計画など官需に強い |
市場注目の銘柄
チャート関連のコラム